Mannitol Baxter Healthcare

Mannitol, the active ingredient in Mannitol Baxter Healthcare, is an osmotic diuretic presented as an intravenous solution for intravenous use. It is employed to lower elevated intracranial and intraocular pressures and to promote diuresis in specific renal conditions. GNH USA supplies Mannitol Baxter Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol acts as an osmotic agent to manage conditions where fluid shifts reduce pressure or support renal output. - Intracranial hypertension: lowers intracranial pressure by drawing water out of brain tissue. - Intraocular hypertension: decreases intraocular pressure in acute glaucoma or ocular surgery. - Acute kidney injury: provides renal protection by maintaining tubular flow and preventing obstruction. - Oliguria: facilitates urine output in patients with reduced kidney perfusion.

Mannitol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort often related to rapid osmotic shifts. - Nausea or vomiting: gastrointestinal upset following infusion. - Electrolyte imbalance: especially hypernatremia due to increased serum sodium. - Fluid overload: signs of edema or pulmonary congestion. - Hypotension: transient drop in blood pressure with rapid administration.

Serious or Rare Side Effects: - Severe hypernatremia: may lead to neurologic symptoms or seizures. - Pulmonary edema: life‑threatening fluid accumulation in the lungs. - Anaphylactic reaction: rare but requires immediate intervention. - Acute renal failure: paradoxical worsening of kidney function. - Severe hypotension: refractory low blood pressure causing organ hypoperfusion.

Mannitol requires careful clinical monitoring to avoid complications. - Assess intracranial pressure: confirm indication before initiation. - Monitor serum electrolytes: check sodium and osmolality regularly. - Infusion rate control: avoid rapid bolus to reduce hypotension risk. - Caution in heart failure: patients may develop fluid overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Loop diuretics: may cause profound electrolyte disturbances. - Nephrotoxic agents (e.g., aminoglycosides): increase risk of renal injury. - Other osmotic agents: additive osmotic load can exacerbate fluid shifts.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effects. - NSAIDs: can blunt renal protective benefits. - Insulin: osmotic changes may affect glucose control. - Anticoagulants: altered plasma volume may influence coagulation parameters.